New therapy harnesses patients’ blood cells to fight tumors

Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide a new treatment option to cancer patients, potentially bypassing radiation therapies and harsh chemotherapy drugs.

Leave A Comment

Your email address will not be published. Required fields are marked *